
Solanezumab, a Top Alzheimer’s Experimental Drug, Launches New Phase 3 Trial
VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.
VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.
VIDEO + ARTICLE Researchers at Johns Hopkins Medicine surgically implanted a pacemaker-like device into the brain of a patient in the early stages of Alzheimer’s
VIDEO & ARTICLE In trials, the most effective Alzheimer’s treatment so far is IVIG. At $50,000 per year, learn how scientists hope to bring down
Learn how Medicare has just added payment for more dementia therapy. Previously, therapy had to improve a condition. Now, maintaining it or even preventing & slowing deterioration are covered.
VIDEO Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’
Alzheimer’s & Dementia Weekly is providing its regular stream of news services without interruption. Catch all the latest updates here, on Facebook or on Twitter.
Moving a parent into an assisted living community requires patience, understanding and compassion. Ease this life change for your family member. These four tips can help make the transition easier for all.
SEMINAR VIDEO: Watch Dr. Terry Barclay share his passion: To help patients and families thrive – not just survive – when living with Alzheimer’s.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.